Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

• Status: Unknown status
• Trial end date: 2014-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dr.Vandana Bansal
• Treatments: Aspirin; Calcium heparin; Dalteparin; Heparin; Heparin, Low-Molecular-Weight; Tinzaparin

Criteria

Inclusion Criteria:

• Aged between 19 to 35 years;

• Basal follicle-stimulating hormone (FSH) levels of ≤8 IU/l

• Body mass index (BMI) between 19 kg/m2 and 25 kg/m2

• Presence of both ovaries; ≥2 previous IVF failures

• Good quality embryos for transfer

• Endometrial thickness between 10 mm and 14 mm

Exclusion Criteria:

• Polycystic ovary syndrome

• Endometriosis